KOWIESKI MARK (Chief Financial Officer) reported 1 transaction at EVOKE PHARMA INC
Review the transaction codes below to understand the nature of each event.
Filed: 12/17/2025ACC: 0001193125-25-322640
Officer· Chief Financial Officer
Since May 2024
-42.11K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
42.11K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−11.81K
Price / share
—
Trade value
—
% of position
New position
12/16/2025
11.81K→0.00
Total
Net shares
−11.81K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/16/2025 | U · U | −11.81K | — | — | New position | 11.81K | 0.00 |
| Total | −11.81K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
17.29K shares
Shares
−17.29K
Strike price
5.27
Held after
0.00
Exercisable
—
12/17/2025
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
13K shares
Shares
−13K
Strike price
4.45
Held after
0.00
Exercisable
—
12/17/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock17.29K shares | 12/17/2025 | D · Disposition | −17.29K | 5.27 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock13K shares | 12/17/2025 | D · Disposition | −13K | 4.45 | — | 0.00 |